Enteric coated risedronate 35mg for the treatment of osteoporosis

Description

In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Rukshen Weerasooriya

Prof Rukshen Weerasooriya

ECG Cases with Traces

Dr David Yeo

Dr David Yeo

Gallbladder – When Surgery Is Or Is Not Needed

Dr Susannah Graham & Dr Sanjeev Kumar

Dr Susannah Graham & Dr Sanjeev Kumar

Panel Discussion on Adjuvant Hormone Therapy Post Breast Cancer

Dr Peter Lin

Dr Peter Lin

Covid-19 Infection – What We Know Now

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Ego Seeman

expert

Prof Ego Seeman

Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis

Date published: 7 November 2023